Cell Therapeutics, Inc. (CTI) to Present at Jefferies 2012 Global Healthcare Conference
SEATTLE, Nov. 12, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that management will present at the Jefferies 2012 Global Healthcare Conference on Wednesday, November 14 at 3:00 p.m. Greenwich Meantime/ 10:00 a.m. Eastern/ 7:00 a.m. Pacific time in room Adelphi 3 at the Waldorf Hilton in London.
The presentation will also be webcast live with slides, and available for replay after the presentation. The webcast can be accessed at www.celltherapeutics.com.
About Cell Therapeutics, Inc.
Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.
Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_alert
Contact:
Ed Bell
T: 206.282.7100
F: 206.272.4434
E: invest@ctiseattle.com
www.CellTherapeutics.com/investors
SOURCE Cell Therapeutics, Inc.
RELATED LINKS
http://www.celltherapeutics.com
More by this Source
CTI Announces New Data Presented at EHA 2013 Congress Demonstrating the Safety and Tolerability Profile of Pacritinib in Patients with Myelofibrosis
Jun 17, 2013, 01:30 ET
New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI® in 3rd and 4th Line Salvage Setting With and Without Prior Rituximab Treatment
Jun 17, 2013, 01:15 ET
Cell Therapeutics to Join Russell 3000® and Russell Global Indexes
Jun 17, 2013, 01:00 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.